Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke

Journal of Neurochemistry

Volumn 119, Issue 5, 2011, Pages 1029-1040

  Kumari, Rashmi ^a   Willing, Lisa B ^a   Patel, Shyama D ^a   Baskerville, Karen A ^b   Simpson, Ian A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b LINCOLN UNIVERSITY   (United States)

Author keywords

blood brain barrier; metalloproteases; neutrophil; stroke; tissue inhibitors of metalloproteases; type 2 diabetes

Indexed keywords

BRAIN ENZYME; COLLAGEN TYPE 4; GELATINASE B; MESSENGER RNA; OCCLUDIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; COLLAGEN DEGRADATION; CONTROLLED STUDY; CONVALESCENCE; DIABETIC DB DB MOUSE; ENZYME ACTIVITY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HYPOXIA-ISCHEMIA, BRAIN; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, MUTANT STRAINS; MICE, OBESE; RECOVERY OF FUNCTION; STROKE; UP-REGULATION;

MUS;

EID: 81255135828     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07487.x     Document Type: Article

References (48)

1. Amantea D., Russo R., Gliozzi M., Fratto V., Berliocchi L., Bagetta G., Bernardi G., and, Corasaniti M. T., (2007) Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. Int. Rev. Neurobiol. 82, 149-169.
2. Antonetti D. A., Barber A. J., Khin S., Lieth E., Tarbell J. M., and, Gardner T. W., (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47, 1953-1959. (Pubitemid 28549205)
3. Asahi M., Asahi K., Jung J. C., del Zoppo G. J., Fini M. E., and, Lo E. H., (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1689.
4. Asahi M., Sumii T., Fini M. E., Itohara S., and, Lo E. H., (2001a) Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 12, 3003-3007. (Pubitemid 32882025)
5. Asahi M., Wang X., Mori T., Sumii T., Jung J. C., Moskowitz M. A., Fini M. E., and, Lo E. H., (2001b) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732. (Pubitemid 32904971)
6. Baker A. H., Sica V., Work L. M., et al. (2007) Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc. Natl. Acad. Sci. USA 104, 3597-3602. (Pubitemid 46364204)
7. Bonoiu A., Mahajan S. D., Ye L., et al. (2009) MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res. 1282, 142-155.
8. Bowes M. P., Rothlein R., Fagan S. C., and, Zivin J. A., (1995) Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45, 815-819.
9. Chen W., Hartman R., Ayer R., Marcantonio S., Kamper J., Tang J., and, Zhang J. H., (2009) Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J. Neurochem. 111, 726-736.
10. Clark A. W., Krekoski C. A., Bou S. S., Chapman K. R., and, Edwards D. R., (1997) Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci. Lett. 238, 53-56. (Pubitemid 28015782)
11. Devraj K., Geguchadze R., Klinger M. E., Freeman W. M., Mokashi A., Hawkins R. A., and, Simpson I. A., (2009) Improved membrane protein solubilization and clean-up for optimum two-dimensional electrophoresis utilizing GLUT-1 as a classic integral membrane protein. J. Neurosci. Methods 184, 119-123.
12. Dietrich W. D., Alonso O., and, Busto R., (1993) Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24, 111-116. (Pubitemid 23014392)
13. Dzwonek J., Rylski M., and, Kaczmarek L., (2004) Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567, 129-135. (Pubitemid 38686435)
14. Elgebaly M. M., Prakash R., Li W., Ogbi S., Johnson M. H., Mezzetti E. M., Fagan S. C., and, Ergul A., (2010) Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J. Cereb. Blood Flow Metab. 30, 1928-1938.
15. Ferland-McCollough D., Ozanne S. E., Siddle K., Willis A. E., and, Bushell M., (2010) The involvement of microRNAs in Type 2 diabetes. Biochem. Soc. Trans. 38, 1565-1570.
16. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J. C., Kawase M., Massengale J., and, Chan P. H., (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19, 1020-1028. (Pubitemid 30173725)
17. Hirsch S., and, Gordon S., (1983) Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics 18, 229-239. (Pubitemid 13002186)
18. Hossain P., Kawar B., and, El Nahas M., (2007) Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med. 356, 213-215. (Pubitemid 46143224)
19. Hu Q., Chen C., Yan J., et al. (2009) Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp. Neurol. 216 (1), 35-46.
20. Jin R., Yang G., and, Li G., (2010) Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol. Dis. 38, 376-385.
21. Justicia C., Panes J., Sole S., Cervera A., Deulofeu R., Chamorro A., and, Planas A. M., (2003) Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J. Cereb. Blood Flow Metab. 23, 1430-1440. (Pubitemid 38018261)
22. Kamada H., Yu F., Nito C., and, Chan P. H., (2007) Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 38, 1044-1049. (Pubitemid 46568472)
23. Krizanac-Bengez L., Hossain M., Fazio V., Mayberg M., and, Janigro D., (2006) Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. Am. J. Physiol. Cell Physiol. 291, C740-C749. (Pubitemid 44497599)
24. Kumari R., Willing L. B., Krady J. K., Vannucci S. J., and, Simpson I. A., (2007) Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J. Cereb. Blood Flow Metab. 27, 710-718. (Pubitemid 46474614)
25. Kumari R., Willing L. B., Patel S. D., Krady J. K., Zavadoski W. J., Gibbs E. M., Vannucci S. J., and, Simpson I. A., (2010) The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. J. Cereb. Blood Flow Metab. 30 (2), 352-360.
26. Lambert E., Dasse E., Haye B., and, Petitfrere E., (2004) TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198. (Pubitemid 38251351)
27. Magnoni S., Baker A., George S. J., Duncan W. C., Kerr L. E., McCulloch J., and, Horsburgh K., (2004) Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol. Dis. 17, 188-197. (Pubitemid 39345775)
28. Montaner J., Alvarez-Sabin J., Molina C. A., Angles A., Abilleira S., Arenillas J., and, Monasterio J., (2001) Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32, 2762-2767. (Pubitemid 33134461)
29. Paljarvi L., Rehncrona S., Soderfeldt B., Olsson Y., and, Kalimo H., (1983) Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol. 60, 232-240. (Pubitemid 13025680)
30. Planas A. M., Sole S., and, Justicia C., (2001) Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol. Dis. 8, 834-846. (Pubitemid 33055599)
31. Reijerkerk A., Kooij G., van der Pol S. M., Khazen S., Dijkstra C. D., and, de Vries H. E., (2006) Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20, 2550-2552.
32. Rosell A., Foerch C., Murata Y., and, Lo E. H., (2008) Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir. Suppl. 105, 173-178.
33. Rosenberg G. A., (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 8, 205-216.
34. Rosenberg G. A., Estrada E. Y., and, Mobashery S., (2007) Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: differences in response based on strains and solvents. Brain Res. 1133, 186-192. (Pubitemid 46123248)
35. Shaw J. E., Sicree R. A., and, Zimmet P. Z., (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4-14.
36. Singh K. P., Gerard H. C., Hudson A. P., and, Boros D. L., (2004) Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology 111, 343-352. (Pubitemid 38365758)
37. Tejima E., Guo S., Murata Y., Arai K., Lok J., van Leyen K., Rosell A., Wang X., and, Lo E. H., (2009) Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J. Neurotrauma 26, 1935-1941.
38. Tureyen K., Bowen K., Liang J., Dempsey R. J., and, Vemuganti R., (2011) Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. J. Neurochem. 116 (4), 499-507.
39. Uemura S., Matsushita H., Li W., Glassford A. J., Asagami T., Lee K. H., Harrison D. G., and, Tsao P. S., (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88, 1291-1298. (Pubitemid 32587846)
40. Vannucci S. J., Willing L. B., Goto S., Alkayed N. J., Brucklacher R. M., Wood T. L., Towfighi J., Hurn P. D., and, Simpson I. A., (2001) Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab. 21, 52-60. (Pubitemid 32016839)
41. Vecil G. G., Larsen P. H., Corley S. M., Herx L. M., Besson A., Goodyer C. G., and, Yong V. W., (2000) Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61, 212-224. (Pubitemid 30451809)
42. Walker E. J., and, Rosenberg G. A., (2009) TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp. Neurol. 216, 122-131.
43. Wallace J. A., Alexander S., Estrada E. Y., Hines C., Cunningham L. A., and, Rosenberg G. A., (2002) Tissue inhibitor of metalloproteinase-3 is associated with neuronal death in reperfusion injury. J. Cereb. Blood Flow Metab. 22, 1303-1310. (Pubitemid 35285087)
44. Wild S., Roglic G., Green A., Sicree R., and, King H., (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053. (Pubitemid 38579764)
45. Zeni P., Doepker E., Schulze-Topphoff U., Huewel S., Tenenbaum T., and, Galla H. J., (2007) MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro. Am. J. Physiol. Cell Physiol. 293, C855-864. (Pubitemid 47437399)
46. Zhang L., Nair A., Krady K., Corpe C., Bonneau R. H., Simpson I. A., and, Vannucci S. J., (2004) Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J. Clin. Invest. 113, 85-95. (Pubitemid 38541635)
47. Zhao B. Q., Wang S., Kim H. Y., Storrie H., Rosen B. R., Mooney D. J., Wang X., and, Lo E. H., (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441-445.
48. Zhou J., Li J., Rosenbaum D. M., and, Barone F. C., (2011) Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury. J. Cereb. Blood Flow Metab. 31, 924-933.